Publications
- Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab2023 | First Faculty of Medicine
- To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection2022 | First Faculty of Medicine
- Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia2021 | Faculty of Physical Education and Sport, Faculty of Medicine in Pilsen, First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- MS and NMOSD during the pandemic COVID-19 - what have we already learnt?2021 | Faculty of Physical Education and Sport, First Faculty of Medicine
- The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 20212023 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Validation of the Czech Version of the Dysphagia in Multiple Sclerosis Questionnaire (DYMUS)2023 | First Faculty of Medicine
- Progressive multiple sclerosis in the light of the latest findings2023 | First Faculty of Medicine
- Falls in people with multiple sclerosis2023 | First Faculty of Medicine
- Internal comorbidities and complications of multiple sclerosis therapy - don't be caught off guard!2023 | First Faculty of Medicine
- High efficacy treatment since the first attack - an important step in the treatment of multiple sclerosis?2023 | First Faculty of Medicine
Loading network view...